Allorion Therapeutics
Developing novel small molecule drugs against cancer and autoimmune diseases.
$50M Series B+ ·
Led by INCE Capital · Source: fundraisingfox.com
All 2 rounds ↓Signals
X account@AllorionT · created Feb 19, 2021 (5 years old) · 21 followers
Website registeredOct 28, 2019 (7 years old)
TIMELINE · MONEY RAISED
Allorion Therapeutics | 758 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $50M | fundraisingfox.com | ||
| Series A | undisclosed | prnewswire.com |
Timeline
- X account created
- Website created
Founders and team
QD
Qiang Ding Founder
Investors
33SBio Inc.
- EElikon Venture
FFirstLight Capital
IIDG Capital
IINCE Capitallead investor
LLongRiver Investments
MMed-Fine Capital
OOctagon Capital Advisors
QQiming Venture Partnerslead investor
TTF Capital
Companies like Allorion Therapeutics
VVandria$30.7M Series A · Aug 2024AAnaveon$120M Series B+ · Dec 2021
PPeptone$40M Series A · Jun 2022
MModel Medicines$4.1M · Nov 2021
AAtomwiseSeries B+ · Mar 2025MMatchpoint Therapeutics$150M Series B+ · Oct 2026
Other companies backed by INCE Capital
MMaxInsights$30M Seed · Oct 2026
CCoordinate System Intelligence$27.85M Seed · Jun 2025IInfStones$33M Series B+ · Feb 2022
WWeFlySeries A · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/allorion-therapeutics (get a free API key).